116 related articles for article (PubMed ID: 34049223)
1. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas.
Herrero C; Brea J; Pérez-Díaz A; Cuadrado E; Ferreño N; Moiola CP; Colás E; Gil-Moreno A; López-López R; Loza MI; Abal M; Alonso-Alconada L
Biomed Pharmacother; 2021 Aug; 140():111744. PubMed ID: 34049223
[TBL] [Abstract][Full Text] [Related]
2. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
Alonso-Alconada L; Muinelo-Romay L; Madissoo K; Diaz-Lopez A; Krakstad C; Trovik J; Wik E; Hapangama D; Coenegrachts L; Cano A; Gil-Moreno A; Chiva L; Cueva J; Vieito M; Ortega E; Mariscal J; Colas E; Castellvi J; Cusido M; Dolcet X; Nijman HW; Bosse T; Green JA; Romano A; Reventos J; Lopez-Lopez R; Salvesen HB; Amant F; Matias-Guiu X; Moreno-Bueno G; Abal M;
Mol Cancer; 2014 Sep; 13():223. PubMed ID: 25261936
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
6. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.
Long Y; Chong T; Lyu X; Chen L; Luo X; Faleti OD; Deng S; Wang F; He M; Qian Z; Zhao H; Zhou W; Guo X; Chen C; Li X
J Exp Clin Cancer Res; 2022 Oct; 41(1):301. PubMed ID: 36229838
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
[TBL] [Abstract][Full Text] [Related]
8. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
[TBL] [Abstract][Full Text] [Related]
9. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma.
Wei DM; Dang YW; Feng ZB; Liang L; Zhang L; Tang RX; Chen ZM; Yu Q; Wei YC; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 50(3):823-840. PubMed ID: 30355917
[TBL] [Abstract][Full Text] [Related]
10. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
[TBL] [Abstract][Full Text] [Related]
12. Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells.
Zhou W; Zhang Y; Zeng Y; Peng M; Li H; Sun S; Ma B; Wang Y; Ye M; Liu J
Biochimie; 2018 Aug; 151():150-158. PubMed ID: 29906496
[TBL] [Abstract][Full Text] [Related]
13. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
Chen CY; Lin YS; Chen CL; Chao PZ; Chiou JF; Kuo CC; Lee FP; Lin YF; Sung YH; Lin YT; Li CF; Chen YJ; Chen CH
Oncotarget; 2015 Sep; 6(29):26946-59. PubMed ID: 26196246
[TBL] [Abstract][Full Text] [Related]
14. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
Mukerjee A; Ranjan AP; Vishwanatha JK
J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
16. A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells.
Ma S; Cheng J; Wang H; Ding N; Zhou F; Ji R; Zhu L; Zhu C; Pan Y
Carcinogenesis; 2021 Feb; 42(1):93-104. PubMed ID: 32531042
[TBL] [Abstract][Full Text] [Related]
17. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
Sampson A; Peterson BG; Tan KW; Iram SH
Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
[TBL] [Abstract][Full Text] [Related]
19. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2.
San IV; Prost G; Williams JA; Moss SE; Nuber UA
Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587
[TBL] [Abstract][Full Text] [Related]
20. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
